Dengue Vaccine Booster Uptake: Half of Recipients Haven’t Received Second Dose
Dengue Vaccine Booster Uptake Lags in Goiás
Table of Contents
Booster Coverage Concerns
Approximately half of the individuals in Goiás who received their first dose of the dengue vaccine have not yet completed their vaccination schedule with the recommended booster dose. This data, reported on December 27, 2024, raises concerns about achieving optimal and sustained protection against dengue fever within the population.
Importance of Booster Doses
Health officials emphasize that the dengue vaccine requires a booster shot to ensure long-term immunity.The initial dose primes the immune system, while the booster strengthens and extends that response, providing more robust protection against all four dengue virus serotypes. Without the booster, the vaccine’s effectiveness may diminish over time, leaving individuals vulnerable to infection.
Public Health Implications
Low booster uptake could hinder efforts to control dengue outbreaks,especially during peak transmission seasons. Dengue fever remains a importent public health challenge in Brazil, and maintaining high vaccination rates is crucial for reducing the burden of disease and preventing severe complications.